Shuichi Aoki
Tohoku University(JP)Mitsui Mining & Smelting (Japan)(JP)
Publications by Year
Research Areas
Pancreatic and Hepatic Oncology Research, Cholangiocarcinoma and Gallbladder Cancer Studies, Peptidase Inhibition and Analysis, Neuroendocrine Tumor Research Advances, Pancreatitis Pathology and Treatment
Most-Cited Works
- → Dual Programmed Death Receptor‐1 and Vascular Endothelial Growth Factor Receptor‐2 Blockade Promotes Vascular Normalization and Enhances Antitumor Immune Responses in Hepatocellular Carcinoma(2019)400 cited
- → Risk factors of serious postoperative complications after pancreaticoduodenectomy and risk calculators for predicting postoperative complications: a nationwide study of 17,564 patients in Japan(2017)182 cited
- → Regorafenib combined with PD1 blockade increases CD8 T-cell infiltration by inducing CXCL10 expression in hepatocellular carcinoma(2020)145 cited
- → Bradykinin B2Receptor Gene Polymorphism Is Associated With Angiotensin-Converting Enzyme Inhibitor–Related Cough(2000)101 cited
- → Association of polymorphisms of the renin–angiotensin system and bradykinin B2 receptor with ACE-inhibitor-related cough(2002)85 cited
- → Decreased serum carbohydrate antigen 19–9 levels after neoadjuvant therapy predict a better prognosis for patients with pancreatic adenocarcinoma: a multicenter case-control study of 240 patients(2019)